Jing Cheng, MD, PhD

Jing Cheng's research interest is mainly on studying the mechanisms by which dysregulated intracellular signaling contributes to inflammatory disease and tumorigenesis. Specifically, she is focused on the effects of different signaling intermediates on NF-kB activity and trying to identify novel binding partners for MALT1, the effector molecule of the CARMA-BCL10-MALT1 (CBM) signalosome, which play important roles in normal lymphocyte function and lymphomagenesis.